FDA Approved: FENOFIBRATE — Supplemental Application (Cipla USA Inc.)

View source ↗

Summary

FDA notice of a supplemental application for fenofibrate submitted by Cipla USA Inc., likely to update labeling or usage indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemias
• Hyperlipidemia
• Hypertriglyceridemia

Drugs mentioned

• FENOFIBRATE (Fenofibrate)

Snippet

SUPPL AP for FENOFIBRATE (FENOFIBRATE)